Goodchild
Colin Goodchild, Malvern AU
Patent application number | Description | Published |
---|---|---|
20110092482 | METHODS AND COMPOSITIONS - The present invention relates generally to the field of pain management, and in particular, the management of neuropathic or inflammatory pain including a neuropathic or inflammatory component of nociceptive pain. More particularly, the present invention provides methods and compositions which treat, alleviate, prevent, diminish or otherwise ameliorate the symptoms of neuropathic or inflammatory pain. The present invention further contemplates combination therapy involved in the treatment of pain in association with the treatment of a particular disease condition or pathology. The present invention further also provides sustained and slow release formulations, tamper-proof deliver systems and stents, catheters and other mechanical devices coated with formulations which permit sustained or slow release of active ingredients involved in pain management. | 04-21-2011 |
20120277271 | METHODS AND COMPOSITIONS - The present invention relates generally to the field of pain management, and in particular, the management of neuropathic or inflammatory pain including a neuropathic or inflammatory component of nociceptive pain. More particularly, the present invention provides methods and compositions which treat, alleviate, prevent, diminish or otherwise ameliorate the symptoms of neuropathic or inflammatory pain. The present invention further contemplates combination therapy involved in the treatment of pain in association with the treatment of a particular disease condition or pathology. The present invention further also provides sustained and slow release formulations, tamper-proof deliver systems and stents, catheters and other mechanical devices coated with formulations which permit sustained or slow release of active ingredients involved in pain management. | 11-01-2012 |
Colin S. Goodchild, Melbourne AU
Patent application number | Description | Published |
---|---|---|
20150265632 | NEUROACTIVE STEROIDS AND THEIR USE TO FACILITATE NEUROPROTECTION - The present disclosure teaches generally neuroprotection and in particular the use of non-hormonal neuroactive steroids to ameliorate inflammation of the central nervous system (CNS). More specifically, the present claims define methods of treating inflammation or ameliorating a neuroinflammatory-promoting condition in the CNS by administration of a steroid with certain properties formulated in a sulfobutyl ether beta-cyclodextrin composition. The steroid is neuroactive, devoid of hormonal endocrine activity and activates a pregnane X receptor. Examples of such steroids include alphaxalone, alphadolone allopregnanolone, pregnanolone, ganaxolone, hydroxydione, minaxolone, Org20599, Org21465, CT1341 and compounds of Formula (I). Dependent claims further define the type of the neuroinflammatory-promoting conditions, the type of cyclodextrin, the molar ratio of neuroactive steroid to the cyclodextrin and the inclusion of other active agents or excipients in the composition and their nature. | 09-24-2015 |
Colin Stanley Goodchild, Malvern AU
Patent application number | Description | Published |
---|---|---|
20090285862 | METHODS AND COMPOSITION FOR TREATMENT OF INFLAMMATORY PAIN - The present invention relates to the field of pain management, and in particular, the management of inflammatory pain without inducing overt sedation. The present invention features compositions and treatments for inflammatory pain comprising the administration of an amount of an neurokinin (NK) antagonist in combination with a neuronal excitation inhibitor. | 11-19-2009 |
20100316678 | COMBINATION METHODS AND COMPOSITIONS FOR TREATMENT OF NEUROPATHIC PAIN - The present invention relates generally to the field of pain management, and in particular, the management of neuropathic pain. The present invention further provides methods and compositions that treat, alleviate, prevent, diminish or otherwise ameliorate the symptoms of neuropathic pain without inducing overt sedation. The present invention also contemplates combination therapy using one or more NK antagonists in combination with one or more compounds which decrease or inhibit neuronal excitation in the treatment of pain in association with the treatment of a particular disease condition or pathology. | 12-16-2010 |
20110129508 | METHODS AND COMPOSITIONS FOR THE MANAGEMENT OF PAIN USING OMEGA-CONOTOXINS - The present invention relates to the management of pain (nociceptive, neuropathic, inflammatory and disease related pains), using omega-conotoxins alone or in combination with neuronal excitation inhibitors (analgesics). The invention in particular provides methods, protocols, compositions and devices which treat, alleviate, prevent, diminish or otherwise ameliorate the sensation of pain. | 06-02-2011 |
20110224147 | METHODS AND COMPOSITIONS - A method for inducing an analgesic response to inflammatory or neuropathic pain by administration of 1-(2-(4-chlorophenyl)-2-hydroxy)ethyl-4-(3,5-bis(1,1 dimethyl)-4-hydroxyphenyl)methyl piperazine, also called CNSB002 or AM-36, either alone or with an opioid and/or a neurokinin (NK) antagonist. | 09-15-2011 |
20120316146 | ANAESTHETIC FORMULATION - The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are provided in the form of host/guest preparations comprising one or more neuroactive steroid anaesthetics and a cyclodextrin. Particular cyclodextrins contemplated include sulfoalkyl ether cyclodextrins and modified forms thereof. | 12-13-2012 |
20140066417 | ANAESTHETIC FORMULATION - The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are provided in the form of host/guest preparations comprising one or more neuroactive steroid anaesthetics and a cyclodextrin. Particular cyclodextrins contemplated include sulfoalkyl ether cyclodextrins and modified forms thereof. | 03-06-2014 |
Colin Stanley Goodchild, Melbourne AU
Patent application number | Description | Published |
---|---|---|
20080227764 | USE OF PREGNANE-DIONES OR DIOLS AS NEUROPATHIC ANALGESIC AGENTS - The present invention relates to the use of pregnanes in inducing analgesia, preferably without overt sedation, in a mammal in response to neuropathic pain, and compositions and kits therefore. | 09-18-2008 |
Gordon Goodchild, Broomfield, CO US
Patent application number | Description | Published |
---|---|---|
20090262111 | Method and Apparatus for Perspective Inversion - A surgical instrument navigation system is disclosed that allows a surgeon to invert the three-dimensional perspective of the instrument to match their perspective of the actual instrument. A data processor is operable to generate a three-dimensional representation of a surgical instrument as it would visually appear from either of at least two different perspectives and to overlay the representation of the surgical instrument onto an image data of the patient. The image data and the representations can be displayed on a display. | 10-22-2009 |
20110052008 | System and Method for Image Based Sensor Calibration - Apparatus and methods are disclosed for the calibration of a tracked imaging probe for use in image-guided surgical systems. The invention uses actual image data collected from an easily constructed calibration jig to provide data for the calibration algorithm. The calibration algorithm analytically develops a geometric relationship between the probe and the image so objects appearing in the collected image can be accurately described with reference to the probe. The invention can be used with either two or three dimensional image data-sets. The invention also has the ability to automatically determine the image scale factor when two dimensional data-sets are used. | 03-03-2011 |
Greg Goodchild, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20090279424 | METHODS, COMMUNICATION NETWORKS, AND COMPUTER PROGRAM PRODUCTS FOR COMMUNICATING TIME DIVISION MULTIPLEXING TRAFFIC USING A TRAFFIC ENCAPSULATION STANDARD CONFIGURED TO SUPPORT STATISTICAL MULTIPLEXING (STATMUX) TRAFFIC - A communication network is operated by communicating Time Division Multiplexing (TDM) traffic and data (STATMUX) traffic over a single connection, where the single connection may include multiple aggregated lines using a traffic encapsulation standard configured to support STATMUX traffic. | 11-12-2009 |
James Goodchild, Kanata CA
Patent application number | Description | Published |
---|---|---|
20090297152 | WDM PON PROTECTION SCHEME USING A DUAL PORT ARRAYED WAVEGUIDE GRATING (AWG) - A Wavelength Division Multiplexed Passive Optical Network (WDM-PON) includes an Optical Line Terminal (OLT) including a first Arrayed Waveguide Grating (AWG) MUX/DEMUX, and a remote node including a second AWG MUX/DEMUX. Each AWG MUX/DEMUX has at least two input ports for receiving a respective wavelength division multiplexed optical signal, and a plurality of output ports. Each output port of the Optical Line Terminal AWG MUX/DEMUX is coupled to a respective transceiver of the OLT. Each output port of the remote node AWG MUX/DEMUX is coupled to a respective PON having at least one optical network terminal (ONT). Respective first and second optical paths are coupled between corresponding input ports of the first and second AWG MUX/DEMUXs. Means are provided for sourcing seed light of the WDM-PON into a selected one the first and second optical paths. | 12-03-2009 |
20100021164 | WDM PON RF/VIDEO BROADCAST OVERLAY - A system for overlaying an analog broadcast channel in a Wavelength Division Multiplexed Passive Optical Network (WDM-PON). A remote node of the WDM PON includes a MUX/DEMUX for demultiplexing a Wavelength Division Multiplexed (WDM) signal and supplying respective wavelength channels to each one of a plurality of channel fibers; an optical power splitter for supplying the analog broadcast channel to each one of a plurality of distribution paths; and a respective optocoupler connected to each distribution path, each opticoupler coupling the analog broadcast channel into one of the channel fibers. The analog broadcast channel has a wavelength that is outside a wavelength band of the WDM signal. An Optical Network Terminal (ONT), which is connected to one of the channel fibers, includes a triplexer for separating the analog broadcast channel from at least a downlink wavelength channel of the WDM-PON. | 01-28-2010 |
20150200837 | DEMARCATION UNIT ENCLOSURE AND METHOD - The disclosure relates to testing or monitoring a target network transceiver using an intelligent transceiver programmed to perform such testing and to transmit test results to a remote server. One aspect provides a demarcation unit enclosure that includes two ports for the target and intelligent transceivers that are connected by a direct data link. An interface circuit connecting control interfaces of the two transceiver ports polls the target transceiver and passes polled control information to the intelligent transceiver. | 07-16-2015 |
Juliet M. Goodchild, Melbourne AU
Patent application number | Description | Published |
---|---|---|
20150265632 | NEUROACTIVE STEROIDS AND THEIR USE TO FACILITATE NEUROPROTECTION - The present disclosure teaches generally neuroprotection and in particular the use of non-hormonal neuroactive steroids to ameliorate inflammation of the central nervous system (CNS). More specifically, the present claims define methods of treating inflammation or ameliorating a neuroinflammatory-promoting condition in the CNS by administration of a steroid with certain properties formulated in a sulfobutyl ether beta-cyclodextrin composition. The steroid is neuroactive, devoid of hormonal endocrine activity and activates a pregnane X receptor. Examples of such steroids include alphaxalone, alphadolone allopregnanolone, pregnanolone, ganaxolone, hydroxydione, minaxolone, Org20599, Org21465, CT1341 and compounds of Formula (I). Dependent claims further define the type of the neuroinflammatory-promoting conditions, the type of cyclodextrin, the molar ratio of neuroactive steroid to the cyclodextrin and the inclusion of other active agents or excipients in the composition and their nature. | 09-24-2015 |
Juliet Marguerite Goodchild, Malvern AU
Patent application number | Description | Published |
---|---|---|
20120316146 | ANAESTHETIC FORMULATION - The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are provided in the form of host/guest preparations comprising one or more neuroactive steroid anaesthetics and a cyclodextrin. Particular cyclodextrins contemplated include sulfoalkyl ether cyclodextrins and modified forms thereof. | 12-13-2012 |
20140066417 | ANAESTHETIC FORMULATION - The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are provided in the form of host/guest preparations comprising one or more neuroactive steroid anaesthetics and a cyclodextrin. Particular cyclodextrins contemplated include sulfoalkyl ether cyclodextrins and modified forms thereof. | 03-06-2014 |
Martin S. Goodchild, Reach GB
Patent application number | Description | Published |
---|---|---|
20110205083 | SYSTEM AND METHOD FOR COMMUNICATING WITH A TELEMETRIC IMPLANT - A telemetric system ( | 08-25-2011 |
Martin Scott Goodchild, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20090295455 | SYSTEM FOR CONTROLLING AN ELECTRONIC DRIVER FOR A NEBULISER - A system for controlling an electronic driver for a nebuliser or aerosol, the system comprising: an H-bridge driver for connection around a membrane to be driven; a voltage source for applying a voltage to the H-bridge driver; a feedback loop from the H-bridge to a phase shift oscillator, the output of which enters the H-bridge driver; wherein the H-bridge driver includes at least one sense resistor for detecting the phase angle between the applied voltage to the H-bridge driver and the applied current. | 12-03-2009 |
20100140291 | DROPLET SPRAY GENERATION DEVICE - An electronic drive system for a droplet spray generation device ( | 06-10-2010 |
20110180622 | SPRAY GENERATOR - A spray generator ( | 07-28-2011 |
20140125360 | MATRIC POTENTIAL SENSOR AND RELATED METHODS - A matric potential sensor ( | 05-08-2014 |
Sarah Ann Goodchild, Salisbury GB
Patent application number | Description | Published |
---|---|---|
20120244150 | ANTI-VEEV HUMANIZED ANTIBODY - The present disclosure relates to an anti-VEEV humanised antibody or a fragment thereof comprising a framework 1, 2, 3, 4, S or 6 CDR regions independently selected from SEQ ID Nos: 2, 3, 4, 5, 6 or 7 characterised in that the antibody or fragment comprises in the framework at least one amino acid, that positively influences the binding/activity of the antibody, from the original murine antibody 1A3B7, pharmaceutical composition comprising same, methods of preparing the antibody or fragment and use of the antibody or fragment in treatment or prophylaxis, in particular the treatment or prophylaxis of VEEV infection. | 09-27-2012 |
Traci T. Goodchild, Dunwoody, GA US
Patent application number | Description | Published |
---|---|---|
20100266561 | Recovery of Tissue Function Following Administration of B Cells to Injured Tissue - The present invention relates generally to systems and methods of enhancing recovery of function of injured tissue through administration of a composition comprising a relatively pure populations of B lymphocyte cells in a pharmaceutically acceptable carrier to the injured tissue. Kits are provided to aid in purification of B cells from heterogeneous mixtures of cells and administration of B cells to injured tissue. | 10-21-2010 |
William Goodchild, Brighton GB
Patent application number | Description | Published |
---|---|---|
20090091559 | Display Driver Circuits for Organic Light Emitting Diode Displays with Skipping of Blank Lines, Method of Reducing Power Consumption of a Display, Processor Control Code to Implement the Method, and Carrier for the Control Code - Display driver circuits are described for driving organic light emitting diode displays, particularly passive matrix displays with greater efficiency. Display driver control circuitry ( | 04-09-2009 |